In 2023 Irene Nevado lay in hospital with little hope of anything much. She had been born with Cystic fibrosis. At he age of 8 she had contracted a persistent infection of Pseudomonas aeruginosa, which had filled her lungs with fluid, making them unusable. The bacterium was antibiotic resistant. And from that day on her life was filled with misery. All sorts of things were tried,: drugs, different antibiotics, even a lung transplant All to no avail. By 2023 she had come to the end of her road.
At this point Biologist Pilar Domingo-Calap enters the story( as told by the brilliant Nuño Domínguez of El País. For Pilar is an expert in phage therapy. She had been working closely with a team at the Centre for phage therapy at Yale in the USA. Together they had evolved a bacteriophage designed to attack and destroy exactly the strain of Pseudomonas which was plaguing Irene. They put her under ten days of treatment. The result? She now walks talks and leads as busy a normal active life as any human could wish for. She even does 4000m swims to raise money for cystic fibrosis charities. Bacteriophages saved the day.
We’ve often sang their praises here. And Nuño’s article is a brilliant summary of the current state of play, with lots of juicy links to big players, latest developments and so on. A go to for any one interested, although if you don’t speak Spanish you will need your AI translator. All in all it confirms the line we have always taken. Bacteriophage therapy is going to be a vital second method if we are to overcome antibiotic resistant microorganisms. Will you, dear readers, permit us a modest instant of self-congratulation?
#bacteriophages #antibiotic resistant microorganisms #medicine #health #cystic fibrosis
Learning, Science and Society 